CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion

被引:364
|
作者
Herman, AE
Freeman, GJ
Mathis, D
Benoist, C
机构
[1] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Immunol & Immunogenet, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 2004年 / 199卷 / 11期
关键词
autoimmunity; diabetes; costimulation; tolerance; microarray;
D O I
10.1084/jem.20040179
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD4(+) CD25(+) T regulatory cells (Tregs) prevent autoimmune disease, yet little is known about precisely where they exert their influence naturally in a spontaneous autoimmune disorder. Here, we report that Tregs and T effector cells (Teffs) coexist within the pancreatic lesion before type 1 diabetes onset. We find that BDC2.5 T cell receptor transgenic animals contain a small subset of FoxP3 positive CD4(+) CD25(+) CD69(-) cells in the pancreas, actively turning over, expressing the clonotypic receptor, and containing functional regulatory activity. Gene expression profiling confirms that the CD4(+) CD25(+) CD69(-) cells in pancreatic tissue express transcripts diagnostic of regulatory cells, but with significantly higher levels of interleukin 10 and inducible costimulator (ICOS) than their lymph node counterparts. Blockade of ICOS rapidly converts early insulitis to diabetes, which disrupts the balance of Teffs and Tregs and promotes a very broad shift in the expression of the T regulatory-specific profile. Thus, CD4(+) CD25(+) 69(-) Tregs operate directly in the autoimmune lesion and are dependent on ICOS to keep it in a nondestructive state.
引用
收藏
页码:1479 / 1489
页数:11
相关论文
共 50 条
  • [1] Human CD4+CD25+ regulatory T cells
    Baecher-Allan, C
    Viglietta, V
    Hafler, DA
    SEMINARS IN IMMUNOLOGY, 2004, 16 (02) : 89 - 97
  • [2] Regulatory CD4+CD25+ T cells and macrophages: communication between two regulators of effector T cells
    Y. Zhen
    J. Zheng
    Y. Zhao
    Inflammation Research, 2008, 57 : 564 - 570
  • [3] Regulatory CD4+CD25+ T cells and macrophages: communication between two regulators of effector T cells
    Zhen, Y.
    Zheng, J.
    Zhao, Y.
    INFLAMMATION RESEARCH, 2008, 57 (12) : 564 - 570
  • [4] THE EFFECT OF CD4+CD25+ REGULATORY T CELLS ON DENDRITIC CELLS
    Zhang, L. S.
    Li, L. J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 478 - 479
  • [5] Regulation of the NFAT pathway discriminates CD4+CD25+ regulatory T cells from CD4+CD25- helper T cells
    Sumpter, Tina L.
    Payne, Kyle K.
    Wilkes, David S.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2008, 83 (03) : 708 - 717
  • [6] Influence of CD4+CD25+ regulatory T cells on the transendothelial migration of CD4+CD25- T cells
    Bedke, T.
    Kretz, M.
    Mahnke, K.
    Enk, A. H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 : 46 - 46
  • [7] Cure of colitis by CD4+CD25+ regulatory T cells
    Mottet, C
    Uhlig, HH
    Powrie, F
    GASTROENTEROLOGY, 2004, 126 (04) : A283 - A283
  • [8] CD4+CD25+ regulatory T cells in HIV infection
    Nixon, DF
    Aandahl, EM
    Michaëlsson, J
    MICROBES AND INFECTION, 2005, 7 (7-8) : 1063 - 1065
  • [9] CD4+CD25+ regulatory T cells and their therapeutic potential
    Randolph, DA
    Fathman, CG
    ANNUAL REVIEW OF MEDICINE, 2006, 57 : 381 - 402
  • [10] CD4+CD25+ T regulatory cells in renal transplantation
    Cheung, Jason
    Zahorowska, Beata
    Suranyi, Michael
    Wong, Jeffrey K. W.
    Diep, Jason
    Spicer, Stephen T. T.
    Verma, Nirupama D. D.
    Hodgkinson, Suzanne J.
    Hall, Bruce M. M.
    FRONTIERS IN IMMUNOLOGY, 2022, 13